p53 tumour suppressor gene alterations are one of the most frequent genetic events in lung cancer. A subset of patients with p53 mutation and cancer exhibited circulating serum anti-p53 self-antibodies (p53-Ab). The prevalence of these antibodies in lung cancer is currently being analysed in a multi
Prognostic significance of serum p53 protein and p53 antibody in patients with surgical treatment for head and neck squamous cell carcinoma
β Scribed by Vivian Chow; Anthony Po Wing Yuen; King Yin Lam; Wai Kuen Ho; William Ignace Wei
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 79 KB
- Volume
- 23
- Category
- Article
- ISSN
- 1043-3074
- DOI
- 10.1002/hed.1032
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Objectives
This study aims at investigating the prognostic values of serum p53 protein and antiβp53 antibody in patients undergoing surgical treatment for head and neck squamous cell carcinoma (HNSCC).
Methods
Serum p53 protein and antiβp53 antibody concentrations were determined by an enzymeβlinked immunosorbent assay (ELISA) in 75 patients with HNSCC and 28 healthy controls. In 28 patients, formalinβfixed tumor tissues were also available for immunohistochemical staining by an antiβp53 DO7 monoclonal antibody. The results were correlated with the clinicopathologic parameters.
Results
The mean preoperative serum concentration of p53 protein in patients with HNSCC was significantly higher than healthy controls (59.45 pg/mL vs 16.4 pg/mL, p = .007). Preoperative serum p53 antibody was present in 23 (31%) patients and was present in one healthy control. Eighteen (62%) tumor tissues showed p53 overexpression by immunohistochemistry. The presence of serum antiβp53 antibody before operation was associated with a significantly higher incidence (65%) of nodal metastasis compared with 27% nodal metastasis in patients with absence of serum antiβp53 antibody (p = .002).
Conclusion
Preoperative serum p53 antibody was a significant prognostic factor for nodal metastasis of HNSCC. Β© 2001 John Wiley & Sons, Inc. Head Neck 23: 286β291, 2001.
π SIMILAR VOLUMES
## Background: A critical factor for successful organ preservation treatment in head and neck cancer may be selecting tumors that respond to chemotherapy and radiation. previous results in patients indicated that tumors that overexpressed p53 were more sensitive to chemotherapy than those that did
## Abstract ## Background Proteins regulating the cell cycle and cell death are frequently abnormally expressed in cancer. Several of these, particularly p53 and Bclβ2, have been widely suggested as possible prognostic markers in diverse human malignancies. Their role in predicting outcome in squa
## Abstract A major problem in head and neck cancer surgery is the high rate of local relapse (LR). In at least 25% of the surgically treated head and neck squamous cell carcinoma (HNSCC) patients, a genetically defined preneoplastic lesion, also known as βfield,β can be detected in the surgical ma
## Background: For early detection of ulcerative colitis (uc)-associated colorectal cancer (crc), surveillance colonoscopy is recommended in uc patients at high risk. however, poor acceptability deteriorates its effectiveness and a suitable marker for selecting patients at high risk is needed. here
Mutation of the p53 tumor suppressor gene has been demonstrated in a large proportion of human head and neck squamous cell carcinomas (HNSCCs) and has been assumed to play a role in the pathogenesis of these tumors, although no formal evidence of functional aberration has been demonstrated. In this